Article
Structure-Guided Design of Therapeutic Antibodies Targeting SARS-CoV-2 Omicron Variants
2026-06-24
Abstract excerpt
<title>Abstract</title> <p>The ongoing evolution of SARS-CoV-2, particularly the emergence of Omicron subvariants, compromised the effectiveness of many therapeutic antibodies. In this study, we employed a structure-guided computational design strategy to systematically optimize the COV2-2196 antibody for improved neutralization of Omicron variants. Through iterative rounds of computational design and experimenta...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f844ec47-bbcd-5e48-ab50-f245c930b807
- DOI
- 10.21203/rs.3.rs-9917568/v1
